Reckitt's Indivior endeavors to 'gain recognition for addiction,' says CEO
This article was originally published in Scrip
Executive Summary
UK consumer goods firm Reckitt Benckiser plans to list shares of its addiction-focused pharmaceutical spin off Indivior on 23 December on the London Stock Exchnage, subject to approval at a shareholder meeting on 11 December.